Team:Tec-Chihuahua/Description

Erwinions


Abstract

American and European Foulbrood are diseases that affect bee (Apis mellifera) larvae worldwide. In the last two years, 53 countries suffered from these diseases, 6 of them are among the top 10 honey producers. The causal agents of these ailments are gram-positive bacteria: Paenibacillus larvae and Melissococcus plutonius respectively. Nowadays, two techniques for the treatment of Foulbrood are used: antibiotics and incineration of hives. The former promotes the development of antibiotic resistance in bacteria while the latter results unprofitable for beekeepers. Therefore, we propose the production of bee antimicrobial peptides (AMPs) in Escherichia coli to treat P. larvae and M. plutonius infections. Defensin 1, abaecin, defensin 2, and apidaecin are each expressed in a different BL21 (DE3) culture. PelB leader peptide and a 6X His-tag foster adequate expression and further purification. Through mathematical modeling, the diffusivity of PLGA-nanoencapsulated apidaecin is evaluated for future in vivo delivery in the bee system.


Introduction

The most significant agricultural management practice is, without a doubt, pollination. Crops that directly rely on this activity are estimated to have a global price tag of between US$235 and US$577 billion a year. In fact, 87% of the food we consume depends on pollination.1 Apis mellifera ranks as the most frequent species of pollinator for crops worldwide 2 making possible and is responsible for the production of strawberry, alfalfa, avocado, coffee, apples, lemons, among many others.3 Bees improve the food production of 2 billion small farmers around the world helping guarantee the food security of the world population.4


Pollination is the greatest strength of bees, but that's not all they do; the world honey market reported historical highs during 2015, with volumes of operations exceeding 2,300 million dollars. In 2016, Mexico contributed 55,358 tons to the world market, with a value of 2,279 million Mexican pesos. 5 Beekeeping in Mexico has great socio-economic importance since it is considered as one of the main livestock activities generating foreign income 6, emphasizing that the third part of Mexico’s agricultural production depends on bees. 7


Figure 1: Not properly pollinated cucumber, promoting a poor development

Yet in the midst of the highly demanded bee population, beekeepers of multiple continents have suffered severe colony losses in recent years and this issue is ascribed to Colony Collapse Disorder, that corresponds to the 30% annual lost in the number of hives worldwide. The cause of this collapse is unclear, and it is attributed to an infectious synergy of multiple factors including pesticides, nutritional complications due to changes in climate patterns and diseases. 9 While viruses and fungal pathogens have been identified as good indicators of this condition, these pathogens, on their own, are not able to explain all losses, suggesting that honey bee colonies are suffering from compromised immune systems which pathogens

are able to take advantage of. 8 Two highly contagious diseases that affect bee (Apis mellifera) larvae worldwide demonstrates the magnitude of this problem: American and European Foulbrood. In the last two years, 53 countries suffered from these diseases 10 and 6 of them are among the top 10 honey producers. 11

Detailed description

Methodology

Here we present the 8 steps our project involves, all the way from the beginning until the end. For additional information of each step, click on the images!

<b>Step 1: Genetic Design Assembly</b> <br>The first step for us to get our recombinant proteins is to create a functional genetic device. We accomplished this by using some parts from the iGEM part registry, as well as some new synthesized parts. Through ligations and digestions we were able to assemble our genetic design.
<b>Step 2: <i>E. coli</i> Transformation</b> <br> The second step is getting our <i>E. coli BL21(DE3)</i> to have our genes of interest in its DNA, therefore we transformed it with our previously designed vector.
<b>Step 3: IPTG Induction</b> <br> Our vector is designed to produce these AMPs only when we want them to be produced. Once we have a considerable amount of bacterial growth, we are able to induce the T7 polymerase with IPTG, beginning the production of our peptides.
<b>Step 4: Bacteria Sonication</b> <br> Our bacteria are not able to secrete the peptides on their own, therefore we came up with another solution, <b>sonication</b>. It will consist in the cell membrane rupture through fast and strong pulses.
<b>Step 5: Protein Purification</b> <br> Once sonication is done, the peptides are combined with cell residues and other cell components that are not of any use for our purposes. In the genetic design we included a pelB secretion signal and a 6X His-tag. These two parts come in handy in this step, they allow us to separate our peptides from the cellular residues.
<b>Step 6: Different AMP Combination Testing</b> <br> Having 4 different AMPs, its not difficult to think of combinations. We will test all of the different permutations with the previously purified peptides, this way we got to know which was the best sinergy.
<b>Step 7: PLGA Microencapsulation</b> <br> Once we have all the purified peptides, they are still vulnerable to the changing environments inside or outside the bees. Therefore we decided to provide our peptides a shield that would protect them against these conditions. This shield is given in the form of a PLGA microcapsule, a biodegradable copolymer that is commonly used to encapsulate antibiotics or terapeutic components. This microcapsule enables a controlled drug release.
<b>Step 8: In-Liquid-Diet Incorporation</b> <br> Finally, these microcapsules are added to the diet the beekeepers commonly give to the bees. It can be added in any syrup (water and sugar mixture) thanks to the fact that no matter how much sugar concentration, its pH won't vary, it will remain close to neutral.
×